Sun Pharmaceutical (SUNPHARMA) — Financial Results

Sun Pharmaceutical Industries Limited disclosed unaudited Q2 FY26 financial results (quarter ended September 30, 2025) through newspaper publication on November 6, 2025, complying with SEBI LODR Regulations 30 & 33. The results were published in Financial Express and are available on company websites and stock exchange portals. This is a regulatory filing announcement containing the Q2 and half-year ended September 30, 2025 unaudited financial statements signed by Executive Chairman Dalip Shanghvi.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this financial results affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 6 November 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 6 November 2025

SBIN State Bank of India Offer Document SBIN State Bank of India Offer Document UNIONBANK Union Bank of India Financial Results WIPRO Wipro Limited Corporate Action ZYDUSLIFE Zydus Lifesciences Limited Financial Results SBIN State Bank of India Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.